Patent ID: 7640115

Claim:
A method for selecting treatments for a cancer patient, comprising: collecting genomic DNA from the patient; amplifying the HLA DQB1* (Major histocompatibility complex, class II, DQ beta 1) gene from the genomic DNA using an automated PCR thermal sequencer; identifying the amino acids at positions 57 and 67 of the amino acid sequence encoded by the HLA DQB1* (Major histocompatibility complex, class II, DQ beta 1) gene of the patient; determining anti-cancer immunotherapy after cancer resection to have statistically significant probability of prolonging the cancer patient's survival, by determining that Asp is at position 57 and Val is at position 67 of the amino acid sequence encoded by the HLA DQB1* (Mayor histocompatibility complex, class II, DQ beta 1) gene; and selecting anti-cancer immunotherapy after cancer resection, as a treatment for the patient; wherein the cancer of the patient is stomach cancer.